NCT05116189 2026-03-09KEYNOTE-B96Merck Sharp & Dohme LLCPhase 3 Active not recruiting643 enrolled 17 charts 1 FDA
NCT03635567 2026-02-04KEYNOTE-826Merck Sharp & Dohme LLCPhase 3 Completed617 enrolled 29 charts 1 FDA
NCT03740165 2025-10-22KEYLYNK-001Merck Sharp & Dohme LLCPhase 3 Active not recruiting1,367 enrolled 29 charts
NCT00740116 2022-03-15Tranexamic Acid in Surgery of Advanced Ovarian CancerUniversity Hospital, LinkoepingPhase 4 Completed100 enrolled 11 charts
NCT01432015 2017-03-28Fosaprepitant Versus Aprepitant in the Prevention of Chemotherapy Induced Nausea and VomitingGynecologic Oncology AssociatesPhase 4 Completed20 enrolled 5 charts